Association of Physician Specialty With Long-Term Implantable Cardioverter-Defibrillator Complication and Reoperations Rates Insights From the NCDR Implantable Cardioverter-Defibrillator Registry

被引:4
|
作者
Chui, Philip W. [1 ,2 ]
Wang, Yongfei [3 ,4 ]
Ranasinghe, Isuru [5 ]
Mitiku, Teferi Y. [6 ]
Seto, Arnold H. [6 ,7 ]
Rosman, Lindsey [1 ,2 ]
Lampert, Rachel [4 ]
Minges, Karl E. [3 ]
Enriquez, Alan D. [1 ,4 ]
Curtis, Jeptha P. [3 ,4 ]
机构
[1] VA Connecticut Healthcare Syst, Sect Internal Med, West Haven, CT USA
[2] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA
[3] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA
[4] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA
[5] Univ Adelaide, Discipline Med, Adelaide, SA, Australia
[6] UC Irvine, Sch Med, Dept Cardiol, Orange, CA USA
[7] VA Long Beach Hlth Care Syst, Dept Med, Long Beach, CA USA
来源
关键词
cardiac resynchronization therapy; hospitalization; incidence; reoperation; risk; NATIONAL ICD REGISTRY; RISK;
D O I
10.1161/CIRCOUTCOMES.118.005374
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients undergoing implantable cardioverter-defibrillator (ICD) implantations have high rates of long-term device-related complications and reoperations. Whether physician specialty training is associated with differences in long-term outcomes following ICD implantation is unclear. Methods and Results: We linked data from the National Cardiovascular Data Registry ICD Registry with Medicare fee-for-service claims to identify physicians who performed >= 10 index ICDs from 2006 to 2009. We used data from the American Board of Medical Specialties to group the specialty of the implanting physician into mutually exclusive categories: electrophysiologists, interventional cardiologists, general cardiologists, thoracic surgeons, and other specialties. Primary outcomes were long-term device-related complications requiring reoperations or hospitalizations and reoperations for reasons other than complications. We compared the cumulative incidence rates and case-mix adjusted rates of long-term outcomes of index ICD implantations across physician specialties. Our analysis had a median follow-up of 47 months and included 107 966 index ICD implantations. Electrophysiologists had the lowest rates of incident long-term device-related complications (14.1%; interventional cardiologists, 15.3%; general cardiologists, 15.4%; thoracic surgeons, 16.4%; other specialists, 15.2%; P<0.001) and reoperations for reasons other than complications (electrophysiologists, 16.7%; interventional cardiologists, 17.0%; general cardiologists, 18.0%; thoracic surgeons, 18.4%; other specialists, 18.0%; P<0.001). Compared with patients whose ICDs were implanted by electrophysiologists, patients with implantations performed by nonelectrophysiologists were at higher risk of having long-term device-related complications (relative risk for interventional cardiologists: 1.16 [95% CI, 1.08-1.25]; general cardiologists: 1.13 [1.08-1.18]; thoracic surgeons: 1.20 [1.06-1.37]; all P<0.001, but not other specialists: 1.08 [0.99-1.17]; P=0.07). Compared to patients with implantations performed by electrophysiologists, patients with implantations performed by general cardiologists and thoracic surgeons were at higher risk of reoperation for noncomplication causes (relative risk for general cardiologists: 1.10 [1.05-1.15]; thoracic surgeons: 1.16 [1.00-1.33]; both P<0.05). Conclusions: Patients with ICD implantations performed by electrophysiologists had the lowest risks of having long-term device-related complications and reoperations for noncomplication causes. Consideration of physician specialty before ICD implantation may represent an opportunity to minimize long-term adverse outcomes.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Sports and Driving With an Implantable Cardioverter-Defibrillator
    Ferrick, Aileen M.
    Ferrick, Kevin J.
    CARDIOLOGY IN REVIEW, 2017, 25 (01) : 36 - 42
  • [42] TWIDDLERS SYNDROME WITH THE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    MEHTA, D
    LIPSIUS, M
    SURI, RS
    KROL, RB
    SAKSENA, S
    AMERICAN HEART JOURNAL, 1992, 123 (04) : 1079 - 1082
  • [43] IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - EFFECT ON SURVIVAL
    SCHLEPPER, M
    NEUZNER, J
    PITSCHNER, HF
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1995, 18 (03): : 569 - 578
  • [44] Hypertrophic cardiomyopathy and the implantable cardioverter-defibrillator
    Manovel-Sanchez, Ana J.
    Pedrote-Martinez, Alonso
    Arana-Rueda, Eduardo
    de Tejada, Francisco Errazquin-Saenz
    REVISTA ESPANOLA DE CARDIOLOGIA, 2007, 60 (07): : 784 - 784
  • [45] AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR - REPLY
    GARTMAN, DM
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1991, 102 (01): : 162 - 163
  • [46] A prophylactic implantable cardioverter-defibrillator? Discussion
    Bourke
    Brugada
    Crick
    Kuck
    Rosenqvist
    AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 : 133 - 133
  • [47] Aspergillus infection of implantable cardioverter-defibrillator
    Cook, RJ
    Orszulak, TA
    Nkomo, VT
    Shuford, JA
    Edwards, WD
    Ryu, JH
    MAYO CLINIC PROCEEDINGS, 2004, 79 (04) : 549 - 552
  • [48] When is an implantable cardioverter-defibrillator controversial?
    Coats, Andrew J. S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (12) : 1504 - 1506
  • [49] USE OF THE AUTOMATIC IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR
    HARGROVE, WC
    MILLER, JM
    JOSEPHSON, ME
    NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (01): : 63 - 64
  • [50] The subcutaneous implantable cardioverter-defibrillator in review
    Kamp, Nicholas J.
    Al-Khatib, Sana M.
    AMERICAN HEART JOURNAL, 2019, 217 : 131 - 139